PCVX Vaxcyte
- 64.550
- +0.840+1.32%
Vaxcyte News
Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 182.28K in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $Vaxcyte(PCVX.US)$ Officer Wassil Jim intends to sell 3,000 shares of its common stock on May 1, with a total market value of approximately $182.28K. Wassil Jim has re
Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 158.95K in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $Vaxcyte(PCVX.US)$ Officer PICKERING GRANT intends to sell 2,616 shares of its common stock on May 1, with a total market value of approximately $158.95K. PICKERING GR
Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 101.29K in Common Stocks
SEC FILLINGS DISCLOSED/ May 1, $Vaxcyte(PCVX.US)$ Officer Eydelman Mikhail intends to sell 1,667 shares of its common stock on May 1, with a total market value of approximately $101.29K. Eydelman Mi
Vaxcyte(PCVX.US) Officer Sells US$928.85K in Common Stock
$Vaxcyte(PCVX.US)$ Officer PICKERING GRANT sold 15,000 shares of common stock on Apr 23, 2024 at an average price of $61.923 for a total value of $928.85K.Source: Announcement What is statement of cha
Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing
Grant Pickering, Director, CEO, on April 23, 2024, sold 15,000 shares in Vaxcyte (PCVX) for $928,845. Following the Form 4 filing with the SEC, Pickering has control over a total of 772,571 shares of
Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 926.85K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 23, $Vaxcyte(PCVX.US)$ Officer PICKERING GRANT intends to sell 15,000 shares of its common stock on Apr 23, with a total market value of approximately $926.85K. PICKERING
Vaxcyte(PCVX.US) Officer Sells US$490.2K in Common Stock
$Vaxcyte(PCVX.US)$ Officer GUGGENHIME ANDREW sold 8,000 shares of common stock on Apr 18, 2024 at an average price of $61.275 for a total value of $490.2K.Source: Announcement What is statement of cha
Vaxcyte Insider Sold Shares Worth $490,199, According to a Recent SEC Filing
Andrew Guggenhime, President and CFO, on April 18, 2024, sold 8,000 shares in Vaxcyte (PCVX) for $490,199. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 95,679 share
Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 497.2K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 18, $Vaxcyte(PCVX.US)$ Officer GUGGENHIME ANDREW intends to sell 8,000 shares of its common stock on Apr 18, with a total market value of approximately $497.2K. GUGGENHIM
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
The global market study pneumococcal conjugate (PCV) market is ~$8 billion per year, and Vaxcyte Inc (NASDAQ:PCVX) estimates it will grow to ~$12 billion in the next few years. The market is currently
Express News | Needham Reiterates Buy on Vaxcyte, Maintains $95 Price Target
Vaxcyte Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/10/2024 47.26% Needham → $95 Reiterates Buy → Buy 03/12/2024 75.17% Mizuho $69 → $113 Maintains Buy 02/
It's worth buying! Needham: In the wave of mergers and acquisitions in the pharmaceutical industry, these three US stocks are most likely to be acquired
Phathom Pharma, Rhythm, and Vaxcyte are most likely to be targeted by pharmaceutical companies.
Phathom Pharma, Rhythm, Vaxcyte Most Likely Takeover Targets in Pharma - Analyst
Vaxcyte(PCVX.US) Officer Sells US$200.07K in Common Stock
$Vaxcyte(PCVX.US)$ Officer Wassil Jim sold 3,000 shares of Common Stock on Apr 1, 2024 at an average price of $66.689 for a total value of $200.07K.Source: Announcement What is statement of changes in
Vaxcyte(PCVX.US) Officer Sells US$111.23K in Common Stock
$Vaxcyte(PCVX.US)$ Officer Eydelman Mikhail sold 1,667 shares of Common Stock on Apr 1, 2024 at an average price of $66.727 for a total value of $111.23K.Source: Announcement What is statement of chan
Vaxcyte(PCVX.US) Officer Sells US$174.5K in Common Stock
$Vaxcyte(PCVX.US)$ Officer PICKERING GRANT sold 2,616 shares of Common Stock on Apr 1, 2024 at an average price of $66.705 for a total value of $174.5K.Source: Announcement What is statement of change
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
SAN CARLOS, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the cons
Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 178.15K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 1, $Vaxcyte(PCVX.US)$ Officer PICKERING GRANT intends to sell 2,616 shares of its common stock on Apr 1, with a total market value of approximately $178.15K. PICKERING GR
Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 204.3K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 1, $Vaxcyte(PCVX.US)$ Officer Wassil Jim intends to sell 3,000 shares of its common stock on Apr 1, with a total market value of approximately $204.3K. Wassil Jim has red
Analysis
Price Target
No Data
